Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke Pogge von Strandmann

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Journal of Extracellular Vesicles|July 13, 2026
Extracellular Vesicle Release Within Energetic and Quantitative Constraints: Implications for FunctionChristian Preußer, Elke Pogge von Strandmann
Trends in Molecular Medicine|July 31, 2016
Shipping Drug Resistance: Extracellular Vesicles in Ovarian CancerElke Pogge von Strandmann, Rolf Müller
Cancers|September 28, 2021
The Role of Extracellular HSP70 in the Function of Tumor-Associated Immune CellsManuel Linder, Elke Pogge von Strandmann
Frontiers in Immunology|March 14, 2017
Antigen Loss Variants: Catching Hold of Escaping FoesMaulik Vyas, Rolf Müller, Elke Pogge von Strandmann
Annals of Translational Medicine|January 16, 2025
Cell type-specific upregulation of NKG2D ligand MICA in response to APTO253Reem Alkhayer, Viviane Ponath, Elke Pogge von Strandmann
STAR Protocols|May 1, 2024
Protocol to target a promoter region in human embryonic kidney cells using the CRISPR-dCas9 system for single-locus proteomicsReem Alkhayer, Viviane Ponath, Elke Pogge von Strandmann
Annals of Translational Medicine|December 24, 2015
NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cellsElke Pogge von Strandmann, Olga Shatnyeva, Hinrich P Hansen
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 22, 2017
Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillanceBastian Dörsam, Kathrin S Reiners, Elke Pogge von Strandmann
Trends in Cancer|July 19, 2017
Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy FailureElke Pogge von Strandmann, Silke Reinartz, Uwe Wager, et al.
Trends in Molecular Medicine|November 26, 2013
Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancerMaulik Vyas, Ulrike Koehl, Michael Hallek, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Journal of Extracellular Vesicles|July 13, 2026
Extracellular Vesicle Release Within Energetic and Quantitative Constraints: Implications for FunctionChristian Preußer, Elke Pogge von Strandmann
Trends in Molecular Medicine|July 31, 2016
Shipping Drug Resistance: Extracellular Vesicles in Ovarian CancerElke Pogge von Strandmann, Rolf Müller
Cancers|September 28, 2021
The Role of Extracellular HSP70 in the Function of Tumor-Associated Immune CellsManuel Linder, Elke Pogge von Strandmann
Frontiers in Immunology|March 14, 2017
Antigen Loss Variants: Catching Hold of Escaping FoesMaulik Vyas, Rolf Müller, Elke Pogge von Strandmann
Annals of Translational Medicine|January 16, 2025
Cell type-specific upregulation of NKG2D ligand MICA in response to APTO253Reem Alkhayer, Viviane Ponath, Elke Pogge von Strandmann
STAR Protocols|May 1, 2024
Protocol to target a promoter region in human embryonic kidney cells using the CRISPR-dCas9 system for single-locus proteomicsReem Alkhayer, Viviane Ponath, Elke Pogge von Strandmann
Annals of Translational Medicine|December 24, 2015
NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cellsElke Pogge von Strandmann, Olga Shatnyeva, Hinrich P Hansen
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 22, 2017
Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillanceBastian Dörsam, Kathrin S Reiners, Elke Pogge von Strandmann
Trends in Cancer|July 19, 2017
Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy FailureElke Pogge von Strandmann, Silke Reinartz, Uwe Wager, et al.
Trends in Molecular Medicine|November 26, 2013
Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancerMaulik Vyas, Ulrike Koehl, Michael Hallek, et al.
Pageof 11